The stock is poised to make its stock exchange debut on August 24.
The Company has a strong presence in the anti-infective, gastrointestinal (GI), central nervous system (CNS), and women's health sectors
Recommendation: Add; Target price: Rs 670
In April-June 2023-24, the pharmaceutical company declared a net profit of Rs 520.5 crore.
Due to the severe uncertainties caused by the Russia-Ukraine war and the Western sanctions, oil prices reached exceptionally high levels in the April to June quarter of 2022.
This achievement allows the company to strategically expand its footprint in North America.
The company's strong financial performance in Q1 solidifies its prominent position in the iron ore industry.
The gold finance company reported that for the first quarter ended June 30, its earnings increased by more than 21% to Rs 975.12 crore.
Rupee opens at 83.01 against the dollar, compared to the previous close of 82.85.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
